Vor Biopharma Inc.
VOR
$16.10
$1.177.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.98% | 167.04% | -15.01% | 234.08% | -34.69% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 455.03% | 54.22% | -50.20% | -66.78% | 7.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 63.84% | 36.65% | -55.38% | 863.64% | -21.84% |
| Total Current Assets | 9.32% | 165.59% | -15.83% | 216.02% | -32.81% |
|
|
|||||
| Total Current Assets | 9.32% | 165.59% | -15.83% | 216.02% | -32.81% |
| Net Property, Plant & Equipment | -2.22% | 4.68% | 13,708.33% | -99.94% | -4.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.94% | 483.98% | 4.05% | -91.22% | -0.29% |
| Total Assets | 9.18% | 163.35% | -14.19% | 87.88% | -23.50% |
|
|
|||||
| Total Accounts Payable | -79.66% | 479.32% | 32.29% | -82.07% | 147.97% |
| Total Accrued Expenses | -25.49% | 11.65% | -69.53% | 569.02% | -32.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.64% | 11.11% | -- | -- | 1.21% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -36.13% | 33.61% | -67.95% | 251.37% | -10.13% |
|
|
|||||
| Total Current Liabilities | -36.13% | 33.61% | -67.95% | 251.37% | -10.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.24% | -3.10% | -- | -- | -3.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.31% | -74.77% | 44.05% | -- | -- |
| Total Liabilities | 4.57% | -73.83% | 40.36% | 3,856.87% | -6.46% |
|
|
|||||
| Common Stock & APIC | 23.69% | 52.02% | 16.67% | 0.34% | 0.34% |
| Retained Earnings | -19.05% | 59.91% | -39.39% | -321.50% | -7.11% |
| Treasury Stock & Other | -1,821.95% | 241.67% | -14.29% | -39.13% | 4.55% |
| Total Common Equity | 8.45% | 92.62% | -47.80% | -2,378.98% | -31.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.45% | 92.62% | -47.80% | -2,378.98% | -31.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.45% | 92.62% | -47.80% | -2,378.98% | -31.65% |
|
|
|||||